Lataa...

Anti-CD20 monoclonal antibodies: reviewing a revolution

Since the inception of rituximab in the 1990s, anti-CD20 monoclonal antibodies have revolutionised the treatment of B cell hematological malignancies and have become a cornerstone of modern gold-standard practice. Additionally, the potent efficacy of these agents in depleting the B cell compartment...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Hum Vaccin Immunother
Päätekijät: Casan, J. M. L., Wong, J., Northcott, M. J., Opat, S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2018
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6343614/
https://ncbi.nlm.nih.gov/pubmed/30096012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2018.1508624
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!